ROLE OF ENDOGENOUS ENDOTHELIN IN EXTENSION OF RABBIT MYOCARDIAL-INFARCTION

被引:32
作者
KUSUMOTO, K
AWANE, Y
FUJIWARA, S
WATANABE, T
机构
关键词
ENDOTHELIN-1; MYOCARDIAL INFARCTION; RABBIT; MONOCLONAL ANTIBODY; LANGENDORFF HEART;
D O I
10.1097/00005344-199322008-00089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of endogenous endothelin-1 (ET-1) in myocardial infarction was investigated in a rabbit ischemia-reperfusion model and in rabbit Langendorff hearts. AwETN40, a monoclonal antibody against ET-1, at 10 mg/kg i.v. inhibited hypertension and hypotension induced by ET-1 (0.3 nmol/kg i.v.): about 70-100% inhibition lasted for 24 h. In a coronary occlusion (30 min)-reperfusion (24 h) model, AwETN40 (10 mg/kg i.v.) reduced the infarct size from 60.9 +/- 4.6% (infarct region/ischemic region in weight, IgG1kappa control; n = 5) to 37.1 +/- 5.2% (n = 5, p < 0.05). Plasma ET-1 levels were increased significantly by coronary occlusion-reperfusion and returned to control level 24 h after reperfusion. Effects of ET-1 on the coronary vessels and cardiac contractility were studied in the Langendorff heart. ET-1 increased the perfusion pressure from concentrations as low as 10 pM, whereas the developed left ventricular pressure was not altered. These results suggest that ET-1 decreases oxygen supply to the cardiac muscles by constricting coronary vessels and that this, in turn, worsens the ischemic condition of the heart to extend the infarct size.
引用
收藏
页码:S339 / S342
页数:4
相关论文
共 11 条
  • [1] 8-OH-DPAT, FLESINOXAN AND GUANFACINE - SYSTEMIC AND REGIONAL HEMODYNAMIC-EFFECTS OF CENTRALLY ACTING ANTIHYPERTENSIVE AGENTS IN ANESTHETIZED RABBITS
    HOF, RP
    FOZARD, JR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (04) : 864 - 871
  • [2] VASOCONSTRICTOR EFFECTS OF ENDOTHELIN-1 ON MYOCARDIUM MICROCIRCULATION STUDIED BY THE LANGENDORFF PERFUSION METHOD - DIFFERENTIAL SENSITIVITIES AMONG MICROVESSELS
    HOMMA, S
    MIYAUCHI, T
    SUGISHITA, Y
    GOTO, K
    SATO, M
    OHSHIMA, N
    [J]. MICROVASCULAR RESEARCH, 1992, 43 (02) : 205 - 217
  • [3] POSITIVE INOTROPIC ACTION OF NOVEL VASOCONSTRICTOR PEPTIDE ENDOTHELIN ON GUINEA-PIG ATRIA
    ISHIKAWA, T
    YANAGISAWA, M
    KIMURA, S
    GOTO, K
    MASAKI, T
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (04): : H970 - H973
  • [4] Kozma C, 1974, BIOL LABORATORY RABB, P50
  • [5] PHYSIOLOGY AND PHARMACOLOGY OF ENDOTHELINS
    MASAKI, T
    YANAGISAWA, M
    GOTO, K
    [J]. MEDICINAL RESEARCH REVIEWS, 1992, 12 (04) : 391 - 421
  • [6] ENDOTHELIN IS A POSITIVE INOTROPIC AGENT IN HUMAN AND RAT-HEART INVITRO
    MORAVEC, CS
    REYNOLDS, EE
    STEWART, RW
    BOND, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (01) : 14 - 18
  • [7] A SENSITIVE SANDWICH-ENZYME IMMUNOASSAY FOR HUMAN ENDOTHELIN
    SUZUKI, N
    MATSUMOTO, H
    KITADA, C
    MASAKI, T
    FUJINO, M
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 118 (02) : 245 - 250
  • [8] ENDOTHELIN IN MYOCARDIAL-INFARCTION
    WATANABE, T
    SUZUKI, N
    SHIMAMOTO, N
    FUJINO, M
    IMADA, A
    [J]. NATURE, 1990, 344 (6262) : 114 - 114
  • [9] CONTRIBUTION OF ENDOGENOUS ENDOTHELIN TO THE EXTENSION OF MYOCARDIAL INFARCT SIZE IN RATS
    WATANABE, T
    SUZUKI, N
    SHIMAMOTO, N
    FUJINO, M
    IMADA, A
    [J]. CIRCULATION RESEARCH, 1991, 69 (02) : 370 - 377
  • [10] POSITIVE INOTROPIC AND VASOCONSTRICTIVE EFFECTS OF ENDOTHELIN-1 IN INVIVO AND INVITRO EXPERIMENTS - CHARACTERISTICS AND THE ROLE OF L-TYPE CALCIUM CHANNELS
    WATANABE, T
    KUSUMOTO, K
    KITAYOSHI, T
    SHIMAMOTO, N
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S108 - S111